POSICOR

产品概览

About POSICOR

POSICOR is a prescription medication used to lower low‑density lipoprotein cholesterol (LDL‑C) in adults with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. It is indicated for patients who require additional LDL‑C reduction beyond diet, lifestyle changes, and other lipid‑lowering therapies. POSICOR is administered orally once daily, with or without food, and should be taken at the same time each day to maintain consistent plasma levels. The medication is available in tablet form and is supplied in a blister pack containing 30 tablets per bottle. POSICOR is not a substitute for a healthy diet or regular exercise, and patients should continue to follow their healthcare provider’s recommendations for cardiovascular risk management.

Key Benefits & Uses

• Reduces LDL‑C levels by up to 30% when used alone or in combination with other lipid‑lowering agents.
• Improves lipid profile by lowering total cholesterol and triglycerides while modestly increasing high‑density lipoprotein cholesterol.
• Provides a convenient once‑daily dosing schedule that supports adherence to long‑term therapy.

Active Ingredient & Action

The active ingredient in POSICOR is ezetimibe, a selective cholesterol‑absorption inhibitor that blocks the Niemann–Pick C1‑like 1 (NPC1L1) transporter in the small intestine. By inhibiting intestinal absorption of dietary and biliary cholesterol, ezetimibe reduces the amount of cholesterol delivered to the liver, leading to up‑regulation of LDL receptors and increased clearance of LDL‑C from the bloodstream.

Important Notes

Patients should inform their healthcare provider of any history of liver disease, kidney impairment, or use of other lipid‑lowering medications. Routine monitoring of liver function tests is recommended during therapy. POSICOR should not be used during pregnancy or lactation unless the potential benefit outweighs the risk. The medication may interact with other drugs that are metabolized by the liver, so a full medication review is advised before initiating therapy.